0 CHECKOUT
Blood Glucose Monitoring (BGM) Devices - Global Strategic Business Report Product Image

Blood Glucose Monitoring (BGM) Devices - Global Strategic Business Report

  • ID: 338886
  • February 2015
  • Region: Global
  • 358 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Blood Glucose Monitoring (BGM) Devices in US$ Million by the following Product Segments: Blood Glucose Strips, Blood Glucose Meters, and Lancets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 83 companies including many key and niche players such as:

- Abbott Diabetes Care, Inc.
- AgaMatrix, Inc.
- Arkray, Inc.
- Bayer Healthcare
- Bionime Corp.

Note: Product cover images may vary from those shown

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Blood Glucose Strips
Blood Glucose Meters
Lancets

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
BGM Devices: Enabling Efficient Management of the Global Diabetes Epidemic
Table 1: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)
Table 2: Percentage Increase in DM Incidence among Ages 20-79 Worldwide by Geographic Region: 2013-2035 (includes corresponding Graph/Chart)
Table 3: Top Ten Countries Worldwide with the Highest Number of People (in the Age Group 20-79 Years) with DM (in Millions): 2014E & 2035P (includes corresponding Graph/Chart)
Global Diabetes Prevalence: Few Alarming Facts
Global Blood Glucose Monitoring (BGM) Market: Growth Drivers in a Nut Shell
Future Growth Driven by Product Innovations & Advancements
Demand for BGM Products to Witness Varying Patterns in Developed and Developing Markets
Recession in Retrospect and the Road Ahead

2. COMPETITION
The Big Four in the Global BGM Devices Market
Table 4: Leading Players in the Global Blood Glucose Monitoring Devices Market (2014E): Percentage Market Share Breakdown for Abbott, Bayer, LifeScan, Roche, and Others (includes corresponding Graph/Chart)
Select Blood Glucose Meters of Leading Manufacturers (2013): Details of Company, Brand Name, Sample Size Required, Time Taken (Seconds), and Special Features
Competition with Local Pharma Companies Intensifies in Regional Markets
Quality Products at Low Prices: Mantra for Success in the Marketplace
Companies Cater to Local Needs to Garner Share in Regional Markets
Products Fail Revised ISO Accuracy Tolerance Requirements: A Cause for Concern?
Accuracy Tolerance Stipulation Changes to ISO 151971 in 2013 Over 2003 Version

3. MARKET TRENDS, ISSUES AND DRIVERS
Epidemic Nature of Global Diabetes Prevalence: A Strong Growth Driver
A “Silent Killer” in Both Developed as well as Developing Nations
Table 5: Prevalence of Diabetes Mellitus in North America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for the US, Canada and Mexico (includes corresponding Graph/Chart)
Table 6: Prevalence of Diabetes Mellitus in Europe (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 47 Countries in the Region
Table 7: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
Table 8: Prevalence of Diabetes Mellitus in Western Asia, Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
Table 9: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 20 Countries in the Region
Table 10: Prevalence of Diabetes Mellitus in Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
Table 11: Prevalence of Diabetes Mellitus in Middle East & North Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 19 Countries in the Region
Rising Incidence of Type 1 & Type 2 Diabetes in Children and Young People
Diabetes Prevalence Buoyed by Burgeoning Aging Populace
Table 12: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
Table 13: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
Table 14: Life Expectancy at Age 60 and 80 Years
(2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
Table 15: Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Table 16: Aging Population by Age Group in More Developed Countries (1975-2050) (includes corresponding Graph/Chart)
Table 17: Aging Population by Age Group in Less Developed Countries (1975-2050) (includes corresponding Graph/Chart)
Table 18: Aging Population by Age Group in Least Developed Countries (1975-2050) (includes corresponding Graph/Chart)
Targeted Screening of Aging Population Vital to Stem Diabetes Epidemic
Increasing Government Efforts for Better DM Management Bodes Well for the Market
Self-Monitoring of Blood Glucose (SMBG) Remains a Viable Option
After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users on the Move
Strong Smartphone Sales: A Major Opportunity Indicator for Mobile-Based BGM Devices
Table 19: Global Smartphones Sales in Million Units: 2011, 2013, 2015 & 2018 (includes corresponding Graph/Chart)
Table 20: Smartphone Penetration Worldwide for Major Countries (as a Percentage of Mobile Phone Users): 2014 (includes corresponding Graph/Chart)
Table 21: Smartphone Penetration Worldwide (as a Percentage of Total Population) for Major Countries: 2014E (includes corresponding Graph/Chart)
MySugr
Diabetic Management App with Gamification Approach
Rising Significance of Remote Blood Glucose Monitoring Augurs Well for Market Expansion
Blood Glucose Test Strips: The Largest Segment
FDA’s New Guidelines for Test Strips
Factors Affecting Meter Accuracies & its Impact on BGM
New Surveillance Error Grid (SEG) for Monitoring Meter Accuracy
Surging Incidence and Undiagnosed Population in Developing Countries Offer Significant Growth Opportunities
Table 22: Number of Undiagnosed Cases of Diabetes among Adults in Age Group 20-80 Years by Geographic Region: 2014 (includes corresponding Graph/Chart)
China: An Untapped Goldmine for Blood Glucose Monitoring Devices
Rising Diabetic Populace Spurs Growth in the Indian BGM Market

4. TECHNOLOGY INNOVATIONS & ADVANCEMENTS
Artificial Pancreas Technology: A Potential Game Changer?
Non-Invasive Devices: The Next Big Thing in Blood Glucose Monitoring
Major Non-Invasive Blood Glucose Monitoring Devices in Research & Development: 2013
Select Companies’ R&D Initiatives in Non-Invasive Glucose Monitors (2013): Brief Description of Company, Technology, Product, Site, and Key Features
Diasensor 1000: The World’s First Non-Invasive Glucose Sensor
Earlobe Glucose Testing: A New Dimension to Non-Invasive Glucose Monitoring
Israeli Bioengineers Develop a New Non-Invasive Glucose Monitoring Device
Ultrasound Device to Monitor Glucose Levels
Multi-Featured Blood Glucose Monitors
Nanotechnology-based Breathalyzer for Glucose Monitoring
Mobile Prescription Therapies
New Diabetes Management Solutions
Dario by LabStyle
A Smartphone Compatible BGM Device
Quick LLC to Develop iQuickIt Saliva Analyzer
New Bluetooth-based Glucose Meters for Superior Connectivity
Blood Glucose Test Strip Advancements Drive down Prices
Test Strip Reimbursement Rates in Select Developed Nations: 2013
Real World Challenges Confront Non-Invasive & Painless BGM

5. CONTINUOUS GLUCOSE MONITORING SYSTEMS: A MACRO PERSPECTIVE
Continuous Glucose Monitoring (CGM) & Conventional Blood Glucose Monitoring (BGM): Comparison of Key Parameters
CGM Market Gradually Breaks through Barriers to Adoption
Table 23: Penetration Rate (%) of CGM Devices in Type 1 and Type 2 Diabetes Market in the United States: 2013 through 2020 (includes corresponding Graph/Chart)
CGMS: Competitive Landscape
Table 24: Leading Products/Brands in the Global Continuous Glucose Monitoring Market (2013): Percentage Value Market Share Breakdown for Dexcom G4 Platinum, Dexcom Seven Plus, Free Style Navigator, Guardian Real Time, Minimed Paradigm Revel and Others (includes corresponding Graph/Chart)
Medtronic Dominates the Global CGM Devices Market
Recent Noteworthy CGM Innovations of Medtronic
Medtronic Introduces Medtronic Minimed Duo for Continuous Glucose Monitoring
Medtronic Develops Minimed 530G with Enlite
CGM Companies Outsmart Each Other with Innovative Marketing Offers
Apple and Google Betting on Wearable Continuous Glucose Monitors
Researchers at Glucovation to Develop Glucovation SugarSenz CGM Sensor
GlySens Focus on Developing Implantable Continuous Glucose Monitor
EyeSense to Develop Affordable CGM Device
Becton, Dickinson to Develop an Insulin Pump with CGM Sensor
Researchers Develop Prototype of Wearable Closed-Loop System
Intensive Care Units: A Highly Promising Market for CGMs
Key Challenges Hampering Widespread Adoption of CGM Systems

6. DIABETES AND BGM DEVICES: OVERVIEW
What is Diabetes?
Types of Diabetes
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)
Type II Diabetes: Non-Insulin Dependent Diabetes Mellitus ( NIDDM)
NIDDM: Higher Risk of Cardiovascular Disease
Gestational Diabetes
Impaired Fasting Glycaemia (IFG) & Impaired Glucose Tolerance (IGT)
Blood Glucose Monitoring
Blood Glucose Monitoring Devices
Blood Glucose Meters
Blood Glucose Monitoring Meters: A Historical Perspective
Types of Blood Glucose Meters
All-In-One Blood Glucose Meters
Combined Wrist Blood Pressure and Blood Glucose Meters
Wrist-Watch Glucose Meters
BGMs with In-Built Food Monitoring Feature
Continuous Blood Glucose Meters
Talking Blood Glucose Meters
Painless Blood Glucose Meters
Multisite Blood Glucose Meters
Plasma Blood Glucose Meters
Measurement Units
Blood Glucose Strips
Lancets

7. PRODUCT INNOVATIONS/INTRODUCTIONS
iHealth Introduces iHealth Align, World’s Smallest Blood Glucose Monitor
Sanofi Introduces MyStar Extra®, a Self-Monitoring Blood Glucose Meter
Lifescan Unveils Onetouch Verio Blood Glucose Monitoring System
Medtronic Unveils MiniMed® Duo in Europe
Glooko Unveils MeterSync Blue Bluetooth Tool
UniStrip Introduces GenStrip Generic Test Strip
Omron Unveils Advanced Blood Glucose Monitors
ARKRAY USA Announces Compatibility of GLUCOCARD® Blood Glucose Meters with Glooko Mobile App
Integrity Applications Displays GlucoTrack®Model DF-F Glucose Monitoring Device
Omron Introduces Two New Blood Glucose Monitors, HGM111 and HGM112
Procaps Launches New GlucoQuick™
Bayer HealthCare Pharmaceuticals Unveils XT Glucometer and NEXT Test strips under CONTOUR® Brand
GE Healthcare and Bionime Introduce GE100 Blood Glucose Monitoring System
Nova Biomedical Unveils Nova Max™ Blood Glucose Monitoring System
BEURER Launches Three-in-one Blood Glucose Monitor
Bayer Diabetes Care to Launch Glucometer
Cambridge Consultants Design Eco-friendly Blood Glucose Monitor
ARKRAY Unveils Audio-Enabled Blood Glucose Monitoring System
Sanofi Introduces iBGStar iPhone Blood Glucose Meter in Various Countries
Abbott Introduces FreeStyle InsuLinx in Canada
Eidia to Introduce LIFE CHECK
Telcare Displays Cellular Blood Glucose Meter at AADE

8. RECENT INDUSTRY ACTIVITY
Medtronic Takes over Covidien
Integrity Applications Inks Distribution Agreements for GlucoTrack® Model DF-F
Integrity Applications Inks Distribution Agreement for GlucoTrack® Model DF-F with Felkasta JSC
Integrity Applications Obtains CE Mark Approval for GlucoTrack® DF-F
Integrity Applications Signs Distribution Agreement for GlucoTrack® Model DF-F in Turkey
Integrity Applications Signs Distribution Agreement for GlucoTrack® Model DF-F in New Zealand and Australia
Philosys Receives FDA Approval for GMATE® SMART
Abbott Obtains CE Mark for FreeStyle® Libre
Integrity Applications Inks Manufacturing Agreement with Wistron
Bionime Inks Subscription Agreement and Strategic Cooperation Structure Agreement with Sannuo
Dexcom Receives FDA Approval for Dexcom G4® PLATINUM Software
Dexcom Receives FDA Approval for Dexcom SHARE™
Dexcom Receives FDA Approval for Dexcom G4® PLATINUM
Nova StatStrip Glucose Hospital Meter System Obtains FDA Clearance
Animas Corporation Obtains FDA Approval for Animus Vibe Insulin Pump
Nipro Receives FDA Approval for TRUE METRIX™ and TRUE METRIX™ PRO
Abbott Recalls FreeStyle Flash® BGM
Abbott Recalls FreeStyle InsuLinx® BGMS
LifeScan Initiates Recall and Replacement of OneTouch® Verio® IQ BGMs
Lifescan Obtains FDA Approval for OneTouch VerioSync
Telcare BGM® Receives Clearance to Operate on Verizon Network
LabStyle Innovations Inks with InnoMed to Distribute Dario™
Integrity Applications Obtains CE Mark Approval for GlucoTrack® Model DF-F Glucose Monitoring Device
Philosys Obtains FDA Approval for Gmate® VOICE BGM
Abbott Obtains CE Mark for Ketone Monitoring System™ and FreeStyle Optium Neo Blood Glucose
Abbott Obtains FDA Approval for ß-Ketone Monitoring System™ and FreeStyle Precision Pro Blood Glucose
ARKRAY Enters Partnership with Glooko
Tandem Expands Development and Commercialization Agreement with Dexcom
GE Healthcare Signs Licensing Agreement with Bionime
Modz Inks Agreement with Novo Nordisk
Merck Serono Inks Distribution Deal with Mendor
Abbott Renews Non-Exclusive Agreement with INSULET
Pepex Biomedical Inks Manufacturing Agreement with Tech Group
Pharmaco Bags Exclusive Distribution Rights for CareSens Blood Glucose Meters
Roche Obtains FDA Approval for ACCU-CHEK Inform II System
Dexcom Obtains USFDA Approval and CE Mark for Dexcom G4™ PLATINUM CGMS
Abbott Obtains FDA Approval for FreeStyle InsuLinx BGM System
StatStrip™ Glucose Monitor from Nova Receives FDA Approval for Neonatal Testing
Philosys Obtains CE Mark for its Gmate® SMART BGMS
Roche Obtains FDA Approval for Accu-Chek Combo System

9. FOCUS ON SELECT GLOBAL PLAYERS
Abbott Diabetes Care, Inc. (US)
AgaMatrix, Inc. (US)
Arkray, Inc. (Japan)
Arkray USA, Inc. (US)
Bayer Healthcare (US)
Bionime Corp. (Taiwan)
B. Braun Melsungen AG (Germany)
DexCom, Inc. (US)
LifeScan, Inc. (US)
Medtronic (US)
Nipro Diagnostics, Inc. (US)
Nova Biomedical Corporation (US)
Roche Diagnostics Corp. (US)
Terumo Europe NV (Belgium)

10. GLOBAL MARKET PERSPECTIVE
Table 25: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 26: World Historic Review for Blood Glucose Monitoring Devices by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America And Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 27: World 14-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region
Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Blood Glucose Monitoring Devices by Product Segment
Table 28: World Recent Past, Current & Future Analysis for Blood Glucose Strips by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 29: World Historic Review for Blood Glucose Strips by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 30: World 14-Year Perspective for Blood Glucose Strips by Geographic Region
Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 31: World Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 32: World Historic Review for Blood Glucose Meters by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 33: World 14-Year Perspective for Blood Glucose Meters by Geographic Region
Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 34: World Recent Past, Current & Future Analysis for Lancets by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 35: World Historic Review for Lancets by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 36: World 14-Year Perspective for Lancets by Geographic Region
Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Current and Future Analysis
Table 37: Leading 10 States in the US with the Highest Rate (%) of Type 2 Diabetes: 2013 (includes corresponding Graph/Chart)
Table 38: Prevalence of Diabetes Mellitus in North America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for the US, Canada and Mexico (includes corresponding Graph/Chart)
Diabetes in America: Fast Facts
Growth Drivers for BGM Devices Market in a Nut Shell
Blood Glucose Monitoring Meters and Strips Sales Dip during Recession
Technologic Innovations Fuel US SMBG Market
Accuracy: A Major Cause of Concern Plaguing BGM Systems
Drugstores Benefit from the Diabetic Care Category
Competitive Landscape
Table 39: Leading Brands in the US Glucose Test Kits Market (2013): Percentage Breakdown of Value Market Share for Accu Chek Aviva Compact, Accu Chek Aviva Plus, Ascensia Contour, Freestyle Lite, Lifescan One Touch Ultra, and Others (includes corresponding Graph/Chart)
Leading BGM Meters in the United States: Brief Description of Manufacturer, Brand, Sample Size and Key Features
Manufactures under Pressure to Reduce Prices of Strips
Other Challenges Facing Market Participants
Regulatory Scenario
FDA’s Proposal to Improve Blood Glucose Meter Accuracy in Critical Care Units Gathers Criticism
Regulations on Lancet Needles to be made More Stringent by FDA
TGC Protocols: A Key Driver for Point of Care BGM Market
Table 40: US Blood Glucose Strips Market (2014E): Percentage Share Breakdown of Dollar Sales for SMBG Strips and POC Glucose Strips (includes corresponding Graph/Chart)
Product Launches
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 41: US Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 42: US Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 43: US 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current and Future Analysis
Product Launch
B.Market Analytics
Table 44: Canadian Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 45: Canadian Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 46: Canadian 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current and Future Analysis
Japan: A Leading Medical Device Exporting Nation
Product Launch
Arkray, Inc.
A Key Japanese Player
B.Market Analytics
Table 47: Japanese Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 48: Japanese Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 49: Japanese 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current and Future Scenario
Prevalence of Diabetes in Europe: Aging Population Dominate
Table 50: Prevalence of Diabetes Mellitus in Europe (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 47 Countries in the Region
Obesity: A Major Cause of Diabetes in Europe
Diabetes Care in Europe Riddled with Challenges
St. Vincent Declaration: A Step in the Right Direction
B.Market Analytics
Table 51: European Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region
France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 52: European Historic Review for Blood Glucose Monitoring Devices by Geographic Region
France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 53: European 14-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region
Percentage Breakdown of Revenue in Dollars for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 54: European Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 55: European Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 56: European 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 57: French Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 58: French Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 59: French 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Current and Future Analysis
Product Launch
B. Braun Melsungen Ag
A Key German Player
B.Market Analytics
Table 60: German Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 61: German Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 62: German 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4c. ITALY
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 63: Italian Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 64: Italian Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 65: Italian 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Current and Future Analysis
Self-Monitoring Blood Glucose Meters Gain Popularity
Five Smallest Blood Glucose Meters in the UK: Brief Description
Product Launches
B.Market Analytics
Table 66: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 67: UK Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 68: UK 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4e. SPAIN
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 69: Spanish Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 70: Spanish Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 71: Spanish 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4f. RUSSIA
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 72: Russian Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 73: Russian Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 74: Russian 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A.Market Analysis
Current and Future Analysis
Product Launch
Strategic Corporate Developments
Terumo Europe Nv
A Key Player
B.Market Analytics
Table 75: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 76: Rest of Europe Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 77: Rest of Europe 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5. ASIA-PACIFIC
A.Market Analysis
Current and Future Analysis
Rising Diabetes Incidence in Asia-Pacific Offers Significant Growth Opportunities
Table 78: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
Table 79: Prevalence of Diabetes Mellitus in Western Asia-Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
High Growth on Cards for SMBG Devices
Asia Suffers from Lack of Focus on Diabetes Care
Healthcare Societies and Associations Spread Awareness of Diabetes
Western Pacific Declaration on Diabetes
Competitive Landscape
Distribution Scenario
B.Market Analytics
Table 80: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region
China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 81: Asia-Pacific Historic Review for Blood Glucose Monitoring Devices by Geographic Region
China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 82: Asia-Pacific 14-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region
Percentage Breakdown of Revenue in Dollars for China, India, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 84: Asia-Pacific Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 85: Asia-Pacific 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5a. CHINA
A.Market Analysis
Current and Future Analysis
China: A Market with Huge Untapped Potential for BGM Devices
Competitive Landscape
B.Market Analytics
Table 86: Chinese Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 87: Chinese Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 88: Chinese 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5b. INDIA
A.Market Analysis
Outlook
Diabetic Epidemic in the Country Spurs Market Growth
Market Restraints
Competitive Landscape
Product Launches
B.Market Analytics
Table 89: Indian Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 90: Indian Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 91: Indian 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
A.Market Analysis
Current and Future Analysis
A Review Of Select Markets
Australia: A Growing Market for Blood Glucose Monitoring Devices
Hong Kong: Low Awareness Levels Offer Opportunities
Malaysia Witness Surge in Chronic Diseases Incidence, including DM
Taiwan: SMBG Devices Market on the Rise
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 92: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 93: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 94: Rest of Asia-Pacific 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA
A.Market Analysis
Current and Future Analysis
Table 95: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 20 Countries in the Region
National Diabetes Programs
Product Launch
B.Market Analytics
Table 96: Latin American Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 97: Latin American Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 98: Latin American 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD
A.Market Analysis
Current and Future Analysis
United Arab Emirates: Rising Diabetic Cases to Propel Market Demand
Key Statistics: Diabetes Prevalence in Middle East and African Regions
Table 99: Prevalence of Diabetes Mellitus in Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
Table 100: Prevalence of Diabetes Mellitus in Middle East & North Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 19 Countries in the Region
Product Launch
Strategic Corporate Developments
B.Market Analytics
Table 101: Rest of World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 102: Rest of World Historic Review for Blood Glucose Monitoring Devices by Product Segment
Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 103: Rest of World 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment
Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 83 (including Divisions/Subsidiaries (97)
The United States (49)
Canada (4)
Japan (4)
Europe (20)
France (1)
Germany (4)
The United Kingdom (3)
Italy (1)
Rest of Europe (11)
Asia-Pacific (Excluding Japan) (16)
Latin America (1)
Middle East (3)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-10 user licence, allowing up to ten users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • General Electric (GE) Company
  • Becton, Dickinson and Company (BD)
  • Quest Diagnostics, Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.
  • GlaxoSmithKline PLC